When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Van Der Gracht, Esmé ^a,b   Zahner, Sonja ^a   Kronenberg, Mitchell ^a,c  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 36; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL POPULATION; DEPLETION; ENTERITIS; HOMEOSTASIS; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; INTESTINE INJURY; LYMPHOID CELL; REVIEW; ANIMAL; CYTOLOGY; HUMAN; INTESTINE MUCOSA; LYMPHOCYTE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LYMPHOCYTES;

EID: 84984974810     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/9765238     Document Type: Review

References (109)

1. M. D. Kappelman, K. R. Moore, J. K. Allen, and S. F. Cook, "Recent trends in the prevalence of Crohns disease and ulcerative colitis in a commercially insured US population, " Digestive Diseases and Sciences, vol. 58, no. 2, pp. 519-525, 2013.
2. N. A. Molodecky, I. S. Soon, D. M. Rabi et al. , "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, " Gastroenterology, vol. 142, no. 1, pp. 46-54. e42, 2012.
3. D. N. Frank, C. E. Robertson, C. M. Hamm et al. , "Disease phenotype and genotype are associated with shifts in intestinalassociated microbiota in inflammatory bowel diseases, " Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 179-184, 2011.
4. S. S. Kang, S. M. Bloom, L. A. Norian et al. , "An antibioticresponsive mouse model of fulminant ulcerative colitis, " PLoS Medicine, vol. 5, no. 3, article e41, 2008.
5. G. Samak, K. K. Chaudhry, R. Gangwar, D. Narayanan, J. H. Jaggar, and R. Rao, "Calcium/Ask1/MKK7/JNK2/c-Src signalling cascade mediates disruption of intestinal epithelial tight junctions by dextran sulfate sodium, " Biochemical Journal, vol. 465, no. 3, pp. 503-515, 2015.
6. H. Tanaka, M. Takechi, H. Kiyonari, G. Shioi, A. Tamura, and S. Tsukita, "Intestinal deletion of claudin-7 enhances paracellular organic solute flux and initiates colonic inflammation in mice, " Gut, vol. 64, no. 10, pp. 1529-1538, 2015.
7. A. Buda, G. Hatem, H. Neumann et al. , "Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: A pilot study, " Journal of Crohns and Colitis, vol. 8, no. 4, pp. 304-311, 2014.
8. W. Fries, M. C. Renda, M. A. Lo Presti et al. , "Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of crohns disease in Southern Italy, " American Journal of Gastroenterology, vol. 100, no. 12, pp. 2730-2736, 2005.
9. R. K. Boyapati, A. G. Rossi, J. Satsangi, andG. Ho, "Gutmucosal DAMPs in IBD: frommechanisms to therapeutic implications, " Mucosal Immunology, vol. 9, no. 3, pp. 567-582, 2016.
10. A. M. Piccinini andK. S. Midwood, "DAMPening inflammation by modulating TLR signalling, " Mediators of Inflammation, vol. 2010, Article ID672395, 21 pages, 2010.
11. A. Fuchs, W. Vermi, J. S. Lee et al. , "Intraepithelial type 1 innate lymphoid cells are a unique subset of il-12-And il-15-responsive ifn-producing cells, " Immunity, vol. 38, no. 4, pp. 769-781, 2013.
12. I. Martinez-Gonzalez, C. A. Steer, and F. Takei, "Lung ILC2s link innate and adaptive responses in allergic inflammation, " Trends in Immunology, vol. 36, no. 3, pp. 189-195, 2015.
13. M. R. Hepworth, T. C. Fung, S. H. Masur et al. , "Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells, " Science, vol. 348, no. 6238, pp. 1031-1035, 2015.
14. C. H. Kim, S. Hashimoto-Hill, and M. Kim, "Migration and tissue tropism of innate lymphoid cells, " Trends in Immunology, vol. 37, no. 1, pp. 68-79, 2016.
15. A. Eken, A. K. Singh, P. M. Treuting, and M. Oukka, "IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism, " Mucosal Immunology, vol. 7, no. 1, pp. 143-154, 2014.
16. S. Buonocore, P. P. Ahern, H. H. Uhlig et al. , "Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology, " Nature, vol. 464, no. 7293, pp. 1371-1375, 2010.
17. C. A. Lindemans, M. Calafiore, A. M. Mertelsmann et al. , "Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration, " Nature, vol. 528, no. 7583, pp. 560-564, 2015.
18. P. Aparicio-Domingo, M. Romera-Hernandez, J. J. Karrich et al. , "Type 3 innate lymphoid cellsmaintain intestinal epithelial stem cells after tissue damage, "The Journal of ExperimentalMedicine, vol. 212, no. 11, pp. 1783-1791, 2015.
19. L. A. Monticelli, L. C. Osborne, M. Noti, S. V. Tran, D. M. W. Zaiss, andD. Artis, "IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions, " Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 34, pp. 10762-10767, 2015.
20. J. VonMoltke, M. Ji, H.-E. Liang, and R. M. Locksley, "Tuft-cellderived IL-25 regulates an intestinal ILC2-epithelial response circuit, " Nature, vol. 529, no. 7585, pp. 221-225, 2016.
21. H. Clevers, "The intestinal crypt, a prototype stemcell compartment, " Cell, vol. 154, no. 2, pp. 274-284, 2013.
22. R. Al-Sadi, D. Ye, M. Boivin et al. , "Interleukin-6modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway, " PLoS ONE, vol. 9, no. 3, article e85345, 2014.
23. A. M. Marchiando, L. Shen, W. V. Graham et al. , "The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding, " Gastroenterology, vol. 140, no. 4, pp. 1208-1218. e2, 2011.
24. A. Negroni, S. Cucchiara, and L. Stronati, "Apoptosis, necrosis, and necroptosis in the gut and intestinal homeostasis, " Mediators of Inflammation, vol. 2015, Article ID250762, 10pages, 2015.
25. R. Ĺopez-Posadas, C. Becker, C. Günther et al. , "Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation, " Journal of Clinical Investigation, vol. 126, no. 2, pp. 611-626, 2016.
26. J. Hampe, A. Franke, P. Rosenstiel et al. , "A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1, " Nature Genetics, vol. 39, no. 2, pp. 207-211, 2007.
27. T. Petnicki-Ocwieja, T. Hrncir, Y.-J. Liu et al. , "Nod2 is required for the regulation of commensal microbiota in the intestine, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15813-15818, 2009.
28. Y. Ogura, D. K. Bonen, N. Inohara et al. , "A frameshiftmutation in NOD2 associated with susceptibility to Crohns disease, " Nature, vol. 411, no. 6837, pp. 603-606, 2001.
29. J.-P. Hugot, M. Chamaillard, H. Zouali et al. , "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohns disease, " Nature, vol. 411, no. 6837, pp. 599-603, 2001.
30. J. D. Söderholm, G. Olaison, E. Lindberg et al. , "Different intestinal permeability patterns in relatives and spouses of patients with Crohns disease: An inherited defect in mucosal defence?" Gut, vol. 44, no. 1, pp. 96-100, 1999.
31. K. R. Youngman, P. L. Simon, G. A. West et al. , "Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells, " Gastroenterology, vol. 104, no. 3, pp. 749-758, 1993.
32. L. Pastorelli, R. R. Garg, S. B. Hoang et al. , "Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimentalTh1/Th2 driven enteritis, " Proceedings of the NationalAcademy of Sciences of theUnited States ofAmerica, vol. 107, no. 17, pp. 8017-8022, 2010.
33. H. Imaeda, K. Takahashi, T. Fujimoto et al. , "Epithelial expression of interleukin-37b in inflammatory bowel disease, " Clinical and Experimental Immunology, vol. 172, no. 3, pp. 410-416, 2013.
34. T. T. Pizarro, M. H. Michie, M. Bentz et al. , "IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohns disease: expression and localization in intestinal mucosal cells, " Journal of Immunology, vol. 162, no. 11, pp. 6829-6835, 1999.
35. M. Cella, A. Fuchs, W. Vermi et al. , "A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity, " Nature, vol. 457, no. 7230, pp. 722-725, 2009.
36. H. Takatori, Y. Kanno, W. T. Watford et al. , "Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22, " Journal of Experimental Medicine, vol. 206, no. 1, pp. 35-41, 2009.
37. M. L. Nagalakshmi, A. Rascle, S. Zurawski, S. Menon, and R. de Waal Malefyt, "Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells, " International Immunopharmacology, vol. 4, no. 5, pp. 679-691, 2004.
38. M. Iizuka and S. Konno, "Wound healing of intestinal epithelial cells, "World Journal of Gastroenterology, vol. 17, no. 17, pp. 2161-2171, 2011.
39. N. Powell, J. W. Lo, P. Biancheri et al. , "Interleukin 6 increases production of cytokines by colonic innate lymphoid cells in mice and patients with chronic intestinal inflammation, " Gastroenterology, vol. 149, no. 2, pp. 456. e15-467. e15, 2015.
40. K. A. Kuhn, N. A. Manieri, T.-C. Liu, and T. S. Stappenbeck, "IL-6 stimulates intestinal epithelial proliferation and repair after injury, " PLoS ONE, vol. 9, no. 12, Article IDe114195, 2014.
41. T. Goretsky, R. Dirisina, P. Sinh et al. , "P53 mediates TNFinduced epithelial cell apoptosis in IBD, " American Journal of Pathology, vol. 181, no. 4, pp. 1306-1315, 2012.
42. A. U. Dignass and D. K. Podolsky, "Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor , " Gastroenterology, vol. 105, no. 5, pp. 1323-1332, 1993.
43. B. Egger, M. W. Buchler, J. Lakshmanan, P. Moore, and V. E. Eysselein, "Mice harboring a defective epidermal growth factor receptor (Waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis, " Scandinavian Journal of Gastroenterology, vol. 35, no. 11, pp. 1181-1187, 2000.
44. P. L. Beck, I. M. Rosenberg, R. J. Xavier, T. Koh, J. F. Wong, and D. K. Podolsky, "Transforming growth factor-mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells, " The American Journal of Pathology, vol. 162, no. 2, pp. 597-608, 2003.
45. G. Pickert, C. Neufert, M. Leppkes et al. , "STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing, " The Journal of Experimental Medicine, vol. 206, no. 7, pp. 1465-1472, 2009.
46. F. Heller, P. Florian, C. Bojarski et al. , "Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution, " Gastroenterology, vol. 129, no. 2, pp. 550-564, 2005.
47. W. A. Rose II, K. Sakamoto, and C. A. Leifer, "TLR9 is important for protection against intestinal damage and for intestinal repair, " Scientific Reports, vol. 2, article 574, 2012.
48. K. Scheibe, I. Backert, S. Wirtz et al. , "IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo, " Gut, 2016.
49. O. Medina-Contreras, A. Harusato, H. Nishio et al. , "Cutting edge: IL-36 receptor promotes resolution of intestinal damage, " Journal of Immunology, vol. 196, no. 1, pp. 34-38, 2016.
50. L. Jostins, S. Ripke, R. K. Weersma et al. , "Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, " Nature, vol. 491, no. 7422, pp. 119-124, 2012.
51. M. Mokry, S. Middendorp, C. L. Wiegerinck et al. , "Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium, " Gastroenterology, vol. 146, no. 4, pp. 1040-1047, 2014.
52. J. Peloquin, G. Goel, H. Huang et al. , "O-002 genes in IBD-Associated risk loci demonstrate genotype-, tissue-, and inflammation-specific patterns of expression in terminal ileum and colonmucosal tissue, " Inflammatory Bowel Diseases, vol. 22, supplement 1, p. S1, 2016.
53. S. Brand, F. Beigel, T. Olszak et al. , "IL-22 is increased in active Crohns disease andpromotes proinflammatorygene expression and intestinal epithelial cell migration, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 290, no. 4, pp. G827-G838, 2006.
54. M. L. Robinette, A. Fuchs, V. S. Cortez et al. , "Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets, " Nature Immunology, vol. 16, no. 3, pp. 306-317, 2015.
55. H. Spits, D. Artis, M. Colonna et al. , "Innate lymphoid cells-A proposal for uniform nomenclature, " Nature Reviews Immunology, vol. 13, no. 2, pp. 145-149, 2013.
56. C. Pearson, E. E. Thornton, B. McKenzie et al. , "ILC3 GMCSF production and mobilisation orchestrate acute intestinal inflammation, " eLife, vol. 5, Article IDe10066, 2016.
57. M. H. Kim, E. J. Taparowsky, and C. H. Kim, "Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut, " Immunity, vol. 43, no. 1, pp. 107-119, 2015.
58. G. Gasteiger, X. Fan, S. Dikiy, S. Y. Lee, and A. Y. Rudensky, "Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs, " Science, vol. 350, no. 6263, pp. 981-985, 2015.
59. C. Vonarbourg and A. Diefenbach, "Multifaceted roles of interleukin-7 signaling for the development and function of innate lymphoid cells, " Seminars in Immunology, vol. 24, no. 3, pp. 165-174, 2012.
60. N. K. Crellin, S. Trifari, C. D. Kaplan, N. Satoh-Takayama, J. P. Di Santo, andH. Spits, "Regulation of cytokine secretion in human CD127+ LTi-like innate lymphoid cells by toll-like receptor 2, " Immunity, vol. 33, no. 5, pp. 752-764, 2010.
61. S. Chaushu, A. Wilensky, C. Gur et al. , "Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease, " PLoS Pathogens, vol. 8, no. 3, Article ID e1002601, 2012.
62. P. H. Kruse, J. Matta, S. Ugolini, and E. Vivier, "Natural cytotoxicity receptors and their ligands, " Immunology and Cell Biology, vol. 92, no. 3, pp. 221-229, 2014.
63. P. R. Giacomin, R. H. Moy, M. Noti et al. , "Epithelial-intrinsic IKK expression regulates group 3 innate lymphoid cell responses and antibacterial immunity, " The Journal of Experimental Medicine, vol. 212, no. 10, pp. 1513-1528, 2015.
64. A. Geremia, C. V. Arancibia-Ćarcamo, M. P. P. Fleming et al. , "IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease, " Journal of ExperimentalMedicine, vol. 208, no. 6, pp. 1127-1133, 2011.
65. J. H. Bernink, C. P. Peters, M. Munneke et al. , "Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues, " Nature Immunology, vol. 14, no. 3, pp. 221-229, 2013.
66. C. Song, J. S. Lee, S. Gilfillanet al. , "Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation, " The Journal of Experimental Medicine, vol. 212, no. 11, pp. 1869-1882, 2015.
67. C. Cayrol and J.-P. Girard, "IL-33: An alarmin cytokine with crucial roles in innate immunity, inflammation and allergy, " Current Opinion in Immunology, vol. 31, pp. 31-37, 2014.
68. M. Scarpa, S. Kessler, T. Sadler et al. , "The epithelial danger signal IL-1 is a potent activator of fibroblasts and reactivator of intestinal inflammation, " The American Journal of Pathology, vol. 185, no. 6, pp. 1624-1637, 2015.
69. R. S. Longman, G. E. Diehl, D. A. Victorio et al. , "CX3CR1+ mononuclear phagocytes support colitis-Associated innate lymphoid cell production of IL-22, " Journal of Experimental Medicine, vol. 211, no. 8, pp. 1571-1583, 2014.
70. H. Y. Kim, Y.-J. Chang, S. Subramanian et al. , "Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity, " Journal of Allergy and Clinical Immunology, vol. 129, no. 1, pp. 216-227. e6, 2012.
71. F. Meylan, E. T. Hawley, L. Barron et al. , "The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells, "Mucosal Immunology, vol. 7, no. 4, pp. 958-968, 2014.
72. A. Mohapatra, S. J. Van Dyken, C. Schneider, J. C. Nussbaum, H.-E. Liang, and R. M. Locksley, "Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis, "Mucosal Immunology, vol. 9, no. 1, pp. 275-286, 2016.
73. J. Mjösberg, J. Bernink, K. Golebski et al. , "The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells, " Immunity, vol. 37, no. 4, pp. 649-659, 2012.
74. J. Ermann, T. Staton, J. N. Glickman, R. deWaalMalefyt, and L. H. Glimcher, "Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-. Rag2-/-(TRUC) mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 25, pp. E2559-E2566, 2014.
75. M. L. Robinette and M. Colonna, "Innate lymphoid cells and the MHC, " HLA, vol. 87, no. 1, pp. 5-11, 2016.
76. N. von Burg, G. Turchinovich, and D. Finke, "Maintenance of immune homeostasis through ILC/T cell interactions, " Frontiers in Immunology, vol. 6, article 416, 2015.
77. T. Ji, C. Xu, L. Sun et al. , "Aryl hydrocarbon receptor activation down-regulates IL-7 and reduces inflammation in a mouse model of DSS-induced colitis, " Digestive Diseases and Sciences, vol. 60, no. 7, pp. 1958-1966, 2015.
78. E. Koroleva, W. Muraoka, C. Spencer et al. , "O-009lymphotoxin links microbiota and group 3 innate lymphoid cells to protect against intestinal inflammation, " Inflammatory Bowel Diseases, vol. 22, supplement 1, pp. S3-S4, 2016.
79. R. H. Duerr, K. D. Taylor, S. R. Brant et al. , "A genome-wide association study identifies IL23R as an inflammatory bowel disease gene, " Science, vol. 314, no. 5804, pp. 1461-1463, 2006.
80. E. Macho-Fernandez, E. P. Koroleva, C. M. Spencer et al. , "Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells, " Mucosal Immunology, vol. 8, no. 2, pp. 403-413, 2015.
81. S. Sawa, M. Lochner, N. Satoh-Takayama et al. , "RORt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota, " Nature Immunology, vol. 12, no. 4, pp. 320-328, 2011.
82. C. L. Zindl, J.-F. Lai, Y. K. Lee et al. , "IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 31, pp. 12768-12773, 2013.
83. M. Muñoz, C. Eidenschenk, N. Ota et al. , "Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection, " Immunity, vol. 42, no. 2, pp. 321-331, 2015.
84. R. Nowarski, R. Jackson, N. Gagliani et al. , "Epithelial IL-18 equilibrium controls barrier function in colitis, " Cell, vol. 163, no. 6, pp. 1444-1456, 2015.
85. M. Levy, C. A. Thaiss, D. Zeevi et al. , "Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling, " Cell, vol. 163, no. 6, pp. 1428-1443, 2015.
86. S. E. Russell, R. M. Horan, A. M. Stefanska et al. , "IL-36 expression is elevated in ulcerative colitis and promotes colonic inflammation, " Mucosal Immunology, 2016.
87. R. Al-Sadi, S. Guo, D. Ye, and T. Y. Ma, "TNF-modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of Elk-1, " American Journal of Pathology, vol. 183, no. 6, pp. 1871-1884, 2013.
88. I. Trivedi and S. B. Hanauer, "Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases, " Expert Opinion on Drug Safety, vol. 14, no. 12, pp. 1915-1934, 2015.
89. Y. Nakanishi, T. Sato, and T. Ohteki, "Commensal Grampositive bacteria initiates colitis by inducing monocyte/macrophagemobilization, " Mucosal Immunology, vol. 8, no. 1, pp. 152-160, 2015.
90. M. Roulis, M. Armaka, M. Manoloukos, M. Apostolaki, and G. Kollias, "Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 13, pp. 5396-5401, 2011.
91. T. Glatzer, M. Killig, J. Meisig et al. , "RORt+ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44, " Immunity, vol. 38, no. 6, pp. 1223-1235, 2013.
92. N. Powell, A. W. Walker, E. Stolarczyk et al. , "The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells, " Immunity, vol. 37, no. 4, pp. 674-684, 2012.
93. M. Coccia, O. J. Harrison, C. Schiering et al. , "IL-1 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+Th17 cells, " Journal of ExperimentalMedicine, vol. 209, no. 9, pp. 1595-1609, 2012.
94. J. S. Lee, C. M. Tato, B. Joyce-Shaikh et al. , "Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability, " Immunity, vol. 43, no. 4, pp. 727-738, 2015.
95. M. Zhang, G. Wang, Y. Tao, and H. Zhang, "The proinflammatory effect and molecular mechanism of IL-17 in the intestinal epithelial cell line HT-29, " Journal of BUON, vol. 20, no. 1, pp. 120-127, 2015.
96. M. Friedrich, J. Diegelmann, F. Beigel, and S. Brand, "IL-17A alone weakly affects the transcriptome of intestinal epithelial cells but strongly modulates the TNF-induced expression of inflammatory mediators and inflammatory bowel disease susceptibility genes, " Inflammatory Bowel Diseases, vol. 20, no. 9, pp. 1502-1515, 2014.
97. G. D. Rak, L. C. Osborne, M. C. Siracusa et al. , "IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing, " Journal of Investigative Dermatology, vol. 136, no. 2, pp. 487-496, 2016.
98. A. Waddell, J. E. Vallance, P. D. Moore et al. , "IL-33 signaling protects frommurine oxazolone colitis by supporting intestinal epithelial function, " Inflammatory Bowel Diseases, vol. 21, no. 12, pp. 2737-2746, 2015.
99. F. Gerbe, E. Sidot, D. J. Smyth et al. , "Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites, " Nature, vol. 529, no. 7585, pp. 226-230, 2016.
100. M. R. Howitt, S. Lavoie, M. Michaud et al. , "Tuft cells, tastechemosensory cells, orchestrate parasite type 2 immunity in the gut, " Science, vol. 351, no. 6279, pp. 1329-1333, 2016.
101. L. A. Monticelli, G. F. Sonnenberg, M. C. Abt et al. , "Innate lymphoid cells promote lung-Tissue homeostasis after infectionwith influenza virus, " Nature Immunology, vol. 12, no. 11, pp. 1045-1054, 2011.
102. C. L. Leaphart, F. Qureshi, S. Cetin et al. , "Interferon-inhibits intestinal restitution by preventing gap junction communication between enterocytes, " Gastroenterology, vol. 132, no. 7, pp. 2395-2411, 2007.
103. A. R. Muzaki, P. Tetlak, J. Sheng et al. , "Intestinal CD103+CD11b-dendritic cells restrain colitis via IFN-induced anti-inflammatory response in epithelial cells, " Mucosal Immunology, vol. 9, no. 2, pp. 336-351, 2016.
104. H. H. Uhlig, B. S. McKenzie, S. Hue et al. , "Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology, " Immunity, vol. 25, no. 2, pp. 309-318, 2006.
105. M. R. Hepworth, L. A. Monticelli, T. C. Fung et al. , "Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria, " Nature, vol. 498, no. 7452, pp. 113-117, 2013.
106. H. Li, L. E. Richert-Spuhler, T. I. Evans et al. , "Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection, " PLoS Pathogens, vol. 10, no. 12, article e1004551, 2014.
107. H. N. Kløverpris, S. W. Kazer, J. Mjösberg et al. , "Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression, " Immunity, vol. 44, no. 2, pp. 391-405, 2016.
108. A. Schuetz, C. Deleage, I. Sereti et al. , "Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation, " PLoS Pathogens, vol. 10, no. 12, Article IDe1004543, 2014.
109. T. Cupedo, N. K. Crellin, N. Papazian et al. , "Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells, " Nature Immunology, vol. 10, no. 1, pp. 66-74, 2009